Paving new pathways.
Jeffrey D
JD
Rothstein
D000970:Antineoplastic Agents / Q000494:pharmacology; D001932:Brain Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D018031:Connexin 43 / Q000378:metabolism; D027342:Excitatory Amino Acid Transporter 2 / Q000378:metabolism; D005910:Glioma / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D018698:Glutamic Acid / Q000378:metabolism*; D018091:Receptors, AMPA; D017470:Receptors, Glutamate / Q000187:drug effects / Q000378:metabolism
D000970:Antineoplastic Agents; D018031:Connexin 43; D027342:Excitatory Amino Acid Transporter 2; D018091:Receptors, AMPA; D017470:Receptors, Glutamate; D018698:Glutamic Acid